The HT Vista device is used by vets and vet nurses to screen dermal and subcutaneous masses on dogs.
The company says that with a negative predictive value of 98% clinicians can confidently classify a mass as benign without the need of further invasive tests.
HT Vista also says that, according to a recent client survey, the main features which practices value are the nurse-led ability which is maximising nurse clinics and streamlining efficiency, justification in sampling masses even when they feel innocuous, and the rapid speed of image acquisition and results.
To be in with a chance of winning the device and subscription, delegates must attend the 15-minute Ultra Demo at stand B300 on Friday 22nd March at 4pm.
PS: Whilst you're here, take a moment to see our latest job opportunities for vets.